| Geld/Brief | 50,50 € / 51,00 € |
| Spread | +0,99% |
| Schluss Vortag | 51,00 € |
| Gehandelte Stücke | 0 |
| Tagesvolumen Vortag | 14.174 € |
| Tagestief 51,00 € Tageshoch 51,00 € | |
| 52W-Tief 20,20 € 52W-Hoch 54,00 € | |
| Jahrestief 20,20 € Jahreshoch 54,00 € | |
| Umsatz in Mio. | 3.723 $ |
| Operatives Ergebnis (EBIT) in Mio. | 1.266 $ |
| Jahresüberschuss in Mio. | 963,76 $ |
| Umsatz je Aktie | 5,54 $ |
| Gewinn je Aktie | 1,43 $ |
| Gewinnrendite | +25,89% |
| Umsatzrendite | +25,89% |
| Return on Investment | +7,50% |
| Marktkapitalisierung in Mio. | 27.477 $ |
| KGV (Kurs/Gewinn) | 21,54 |
| KBV (Kurs/Buchwert) | 3,55 |
| KUV (Kurs/Umsatz) | 5,56 |
| Eigenkapitalrendite | +16,52% |
| Eigenkapitalquote | +45,42% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| Düsseldorf | 49,80 € | +0,40% | 49,60 € | 08:13 | |
| Frankfurt | 50,00 € | 0 % | 50,00 € | 08:01 | |
| Gettex | 51,00 € | 0 % | 51,00 € | 08:43 | |
| L&S RT | 51,25 € | +1,99% | 50,25 € | 09:12 | |
| München | 51,00 € | 0 % | 51,00 € | 08:03 | |
| Nasdaq | 56,44 $ | -1,48% | 57,29 $ | 29.10.26 | |
| NYSE | 56,45 $ | -1,54% | 57,335 $ | 29.10.26 | |
| NYSE American | 55,83 $ | -2,60% | 57,32 $ | 29.10.26 | |
| Quotrix | 51,00 € | 0 % | 51,00 € | 07:27 | |
| Stuttgart | 50,00 € | -0,99% | 50,50 € | 08:56 | |
| Tradegate BSX | 50,50 € | -0,98% | 51,00 € | 29.10.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 29.10.26 | 51,50 | 8.972 |
| 28.10.26 | 49,40 | 19.568 |
| 27.10.26 | 40,00 | 3.980 |
| 26.10.26 | 40,00 | 20.975 |
| 23.10.26 | 39,20 | 7.877 |
| 22.10.26 | 36,20 | 0 |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 36,20 € | +42,27% |
| 1 Monat | 31,20 € | +65,06% |
| 6 Monate | 22,40 € | +129,91% |
| 1 Jahr | 25,00 € | +106,00% |
| 5 Jahre | 38,80 € | +32,73% |
| Marktkapitalisierung | 27,48 Mrd. $ |
| Streubesitz | 79,47% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | ADR |
| +2,14% | Paradigm Biocapital Advisors LP |
| +1,85% | Orbis Allan Gray Ltd |
| +1,41% | AllianceBernstein L.P. |
| +1,12% | Deerfield Management Co |
| +0,92% | Deep Track Capital, LP |
| +0,81% | Arrowstreet Capital Limited Partnership |
| +0,76% | BlackRock Inc |
| +0,70% | iShares Biotechnology ETF |
| +0,66% | Sofinnova Ventures |
| +0,64% | AllianceBernstein US L/C Growth Eqty MF |
| +0,57% | Renaissance Technologies Corp |
| +0,57% | Two Sigma Investments LLC |
| +0,51% | First Trust NYSE Arca Biotech ETF |
| +0,50% | American Funds New Perspective A |
| +0,50% | Harding Loevner L.P. |
| +0,49% | Orbis SICAV Intl Eq Inv |
| +0,45% | First Trust Advisors L.P. |
| +0,4% | Citadel Advisors Llc |
| +0,29% | Orbis SICAV Global Bal Instl Inv |
| +0,27% | Qube Research & Technologies |
| +0,27% | Morgan Stanley - Brokerage Accounts |
| +0,24% | Federated Hermes Inc |
| +0,21% | The Goldman Sachs Group Inc |
| +0,2% | Franklin Templeton Inc |
| +0,17% | Pictet Asset Manangement SA |
| +0,17% | Orbis Optimal (US$) Fund |
| +0,16% | Orbis Global Equity Investor |
| +0,16% | UBS Group AG |
| +0,15% | American Growth One D |
| +0,15% | AB American Growth AX USD |
| +0,12% | Pictet-Biotech P USD |
| +0,11% | Orbis OEIC Global Balanced Fixed Fee |
| +0,1% | Orbis Optimal SA USD |
| +0,09% | JOHCM Global Select I GBP |
| +0,08% | Avantis International Equity ETF |
| +0,08% | Federated Hermes Kaufmann R |
| +0,07% | BlackRock Health Sciences Opps Inv A |
| +0,06% | Franklin DynaTech Fund A |
| +0,06% | Federated Hermes Kaufmann Small Cap A |
| +0,06% | Federated Hermes International Leaders A |
| +20,532% | Institutionelle Aktionäre |
| +79,468% | Streubesitz |